Regulus Therapeutics Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Jay Hagan
Chief Executive Officer (CEO)
US$2.6m
Compensación total
| Porcentaje del salario del CEO | 23.9% |
| Permanencia del CEO | 7yrs |
| Participación del CEO | 0.09% |
| Permanencia media de la dirección | 4.8yrs |
| Promedio de permanencia en la Junta Directiva | 7yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$31m |
| Dec 31 2023 | US$3m | US$616k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$29m |
| Jun 30 2023 | n/a | n/a | -US$28m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | US$1m | US$598k | -US$28m |
| Sep 30 2022 | n/a | n/a | -US$29m |
| Jun 30 2022 | n/a | n/a | -US$30m |
| Mar 31 2022 | n/a | n/a | -US$29m |
| Dec 31 2021 | US$2m | US$568k | -US$28m |
| Sep 30 2021 | n/a | n/a | -US$22m |
| Jun 30 2021 | n/a | n/a | -US$15m |
| Mar 31 2021 | n/a | n/a | -US$16m |
| Dec 31 2020 | US$2m | US$552k | -US$16m |
| Sep 30 2020 | n/a | n/a | -US$19m |
| Jun 30 2020 | n/a | n/a | -US$23m |
| Mar 31 2020 | n/a | n/a | -US$21m |
| Dec 31 2019 | US$2m | US$536k | -US$19m |
| Sep 30 2019 | n/a | n/a | -US$22m |
| Jun 30 2019 | n/a | n/a | -US$27m |
| Mar 31 2019 | n/a | n/a | -US$36m |
| Dec 31 2018 | US$2m | US$520k | -US$49m |
| Sep 30 2018 | n/a | n/a | -US$55m |
| Jun 30 2018 | n/a | n/a | -US$60m |
| Mar 31 2018 | n/a | n/a | -US$68m |
| Dec 31 2017 | US$2m | US$475k | -US$72m |
Compensación vs. Mercado: La compensación total de Jay($USD2.57M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD406.04K).
Compensación vs. Ingresos: La compensación de Jay ha aumentado mientras la empresa no es rentable.
CEO
Jay Hagan (54 yo)
7yrs
Permanencia
US$2,574,323
Compensación
Mr. Joseph P. Hagan, also known as Jay, served as Independent Director of Zosano Pharma Corporation since May 22, 2015, until May 10, 2022. He has been the Chief Executive Officer and Director of Regulus T...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 7yrs | US$2.57m | 0.087% $ 101.1k | |
| Chief Financial Officer | 4.8yrs | US$1.07m | 0.0088% $ 10.2k | |
| Senior VP | 13.3yrs | US$1.09m | 0.015% $ 17.8k | |
| President | less than a year | sin datos | 0% $ 0 | |
| VP of Finance & Controller | 4.8yrs | sin datos | sin datos | |
| Senior Vice President of Clinical Operations | 1.5yrs | sin datos | sin datos | |
| Chief Medical Officer | 1.5yrs | sin datos | sin datos | |
| Vice President of Translational Medicine | no data | sin datos | sin datos |
4.8yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 7RG0 se considera experimentado (4.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 7yrs | US$2.57m | 0.087% $ 101.1k | |
| President | less than a year | sin datos | 0% $ 0 | |
| Independent Director | 11.1yrs | US$99.44k | 0.060% $ 69.1k | |
| Member of the Scientific Advisory Board | 5.2yrs | US$1.48m | sin datos | |
| Independent Chairman of the Board | 15.3yrs | US$131.44k | 1.49% $ 1.7m | |
| Chairman of the Scientific Advisory Board & Independent Director | 15.3yrs | US$95.44k | 0.0039% $ 4.5k | |
| Independent Director | 4.9yrs | US$97.44k | 0% $ 0 | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of the Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 7.9yrs | US$93.44k | 0.0027% $ 3.1k | |
| Independent Director | 6.1yrs | US$107.44k | 0.0042% $ 4.9k | |
| Independent Director | 6.9yrs | US$93.44k | 0.0072% $ 8.4k |
7.0yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de 7RG0 se considera experimentada (6.9 años de antigüedad promedio).